Goa, Sept. 18 -- Stringent regulatory controls for vaccines

As we are on the verge of breakthrough in vaccine development for Covid-19, it should be stressed that strict regulatory controls should be the norm all over the world, so that the various vaccines that are being developed are both effective and harmless as far as collateral side effects are concerned.

In the quest for a vaccine however, a British-Swedish company has exercised ethical truthful openness in reporting that one of its participants has developed a serious illness. In fact, the revelation by the companies that one of its patients started showing signs of a rare and devastating neurological condition called as transverse myelitis, the second time someone in one of the...